PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 20 filers reported holding PLX PHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $976 | -20.7% | 7,500 | 0.0% | 0.00% | – |
Q4 2022 | $1,231 | -75.4% | 7,500 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $5,000 | -72.2% | 7,500 | 0.0% | 0.00% | -80.0% |
Q2 2022 | $18,000 | -40.0% | 7,500 | 0.0% | 0.01% | -28.6% |
Q1 2022 | $30,000 | -50.0% | 7,500 | 0.0% | 0.01% | -46.2% |
Q4 2021 | $60,000 | -58.6% | 7,500 | 0.0% | 0.01% | -60.6% |
Q3 2021 | $145,000 | +39.4% | 7,500 | 0.0% | 0.03% | +37.5% |
Q2 2021 | $104,000 | +52.9% | 7,500 | 0.0% | 0.02% | +50.0% |
Q1 2021 | $68,000 | +65.9% | 7,500 | 0.0% | 0.02% | +60.0% |
Q4 2020 | $41,000 | +70.8% | 7,500 | 0.0% | 0.01% | +42.9% |
Q3 2020 | $24,000 | 0.0% | 7,500 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $24,000 | +41.2% | 7,500 | 0.0% | 0.01% | +16.7% |
Q1 2020 | $17,000 | -48.5% | 7,500 | 0.0% | 0.01% | -33.3% |
Q4 2019 | $33,000 | -13.2% | 7,500 | 0.0% | 0.01% | -18.2% |
Q3 2019 | $38,000 | -29.6% | 7,500 | 0.0% | 0.01% | -31.2% |
Q2 2019 | $54,000 | +38.5% | 7,500 | 0.0% | 0.02% | +33.3% |
Q1 2019 | $39,000 | +254.5% | 7,500 | 0.0% | 0.01% | +200.0% |
Q4 2018 | $11,000 | -63.3% | 7,500 | 0.0% | 0.00% | -63.6% |
Q3 2018 | $30,000 | – | 7,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MSD Partners, L.P. | 1,875,000 | $4,556,000 | 0.28% |
Ground Swell Capital, LLC | 48,931 | $119,000 | 0.22% |
Park West Asset Management LLC | 1,473,218 | $3,580,000 | 0.20% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 62,673 | $152,000 | 0.07% |
Eidelman Virant Capital | 27,000 | $63,000 | 0.04% |
MBL Wealth, LLC | 52,000 | $126 | 0.03% |
O'Brien Greene & Co. Inc | 22,340 | $54,000 | 0.02% |
SHUFRO ROSE & CO LLC | 56,800 | $138,000 | 0.01% |
GW&K Investment Management, LLC | 424,921 | $1,033,000 | 0.01% |
EXANE DERIVATIVES | 6,575 | $15,974,000 | 0.01% |